Search This Blog

Monday, December 16, 2019

Guggenheim Starts Relmada Therapeutics Inc (RLMD) at Buy

Guggenheim analyst Yatin Suneja initiates coverage on Relmada Therapeutics Inc.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)